PBAC Generic Medicines Working Group work plans

21 April 2016 - A summary of the work plans for the Generic Medicines Working Group is now available. ...

Read more →

Pharmacy Guild member delegation calls for fairer Section 100 arrangements

20 April 2016 - A delegation of Guild members from the Northern Territory and Western Australia visited Canberra this week to ...

Read more →

New model needed to relieve hepatitis C medicines pressure on pharmacies

20 April 2016 - There is a real risk that people living with chronic hepatitis C may not have timely access ...

Read more →

Survey of healthcare experiences of Australian adults living with rare diseases

19 April 2016 - Few studies have examined whether the healthcare needs of people living with rare diseases are being met. ...

Read more →

Price disclosure - drugs and manners of administration that meet the F2/multi-branded criteria for the 2016 October Cycle

12 April 2016 - A list of drugs and manners of administration that meet the F2/multi-branded criteria (30 month clock) for ...

Read more →

PBAC Guidelines review - co-dependent technologies

12 April 2016 - The public consultation process for the assessment of co-dependent technology chapter of the draft revised PBAC Guidelines ...

Read more →

PBS price cuts cruel pharm innovations

7 April 2016 - Earlier this week, pharmaceutical companies across the country received a substantial financial penalty, as the federal government’s ...

Read more →

Closure of BEACH program after 18 years

11 April 2016 - The current contract with Australian Government Department of Health (DoH) for a partial contribution to the costs ...

Read more →

PBAC Guidelines review update

7 April 2016 - The public consultation process on the draft revised PBAC Guidelines (Version 5.0) is now closed. ...

Read more →

Medicines sector reforms deliver consumer benefits and a sustainable PBS

4 April 2016 - Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine ...

Read more →

'Hundreds of cancer drugs' to enter market in next five years: report

4 April 2016 - Businessman Ron Walker considers himself among the luckiest cancer survivors. ...

Read more →

Affordable access to innovative cancer medicines — don’t forget the prices

4 April 2016 - On 17 September 2015, the much anticipated Senate report on the Availability of new, innovative and specialist ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2016 update

1 April 2016 - The April 2016 issue of the Schedule sees a number of new/revised listings such as arsenic trioxide ...

Read more →

Review of pharmacy remuneration and regulation - message from the Chair

24 March 2016 - Following his delivery of an informative presentation to pharmacists and industry at the Pharmacy Guild's 2016 Australian ...

Read more →

The drug industry can help reduce cancer drug costs

21 March 2016 - Bach and colleagues’ article is particularly relevant because cancer drug expenditure is of major concern. ...

Read more →